Skip to main content
. 2023 Mar 31;33(1):26–32. doi: 10.18865/1722

Table 3.

Patient PSA discussions with providers

Participants
Total (%)
Physician led
CHW led
χ2 value
Significance
Discussed prostate cancer screening with their doctors 73.9 59 26 2.527 .112
Discussed benefits of screening with their doctors 64.3 52 22 2.336 .126
Discussed the risks of screening 42.1 34 14 1.276 .259
Doctors informed that experts disagree about whether men should have a PSA test 23.5 22 5 4.114 .043

PSA, prostate-specific antigen